Review wetenschappelijk congres American Diabetes Association Roelf Holtrop Congresverslag 25 November 2014 Pages: 3 - 4
2. Significance of Hypoglycemia in T2DM Patients in Primary Care (2214-PO) Frank LaverniaDonna M. TomkyAleksandra Vlajnic Congresverslag 25 November 2014 Pages: 4 - 4
3. Is the Fear of Hypoglycemia Associated with Glycemic Imbalance? (2213-PO) Bertrand CariouMichel LievreLaurent Vaur Congresverslag 25 November 2014 Pages: 5 - 5
4. The Association of Neighborhood Characteristics with Diabetes, Obesity, and Other Metabolic Conditions in Older Women (1324-P) Mark D. CorriereWenliang YaoRita R. Kalyani Congresverslag 25 November 2014 Pages: 6 - 6
5. Hyperglycemia Is Associated with Persistently Lower Grip Strength in Older Persons without History of Diabetes: The Rancho Bernardo Study (1318-P) Rita R. KalyaniShengchun KongElizabeth L. Barrett-Connor Congresverslag 25 November 2014 Pages: 6 - 8
6. The Relationship between Olfactory Dysfunction and Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus (1323-P) Haruna SankeTomoya MitaHirotaka Watada Congresverslag 25 November 2014 Pages: 8 - 8
7. Chronic Comorbidities and Glycemic Control in Older Adults with Diabetes (1319-P) Christine LeeGregory Nichols Congresverslag 25 November 2014 Pages: 11 - 11
8. The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naïve People with Type 2 Diabetes (885-P) Philip HomeMohammed KhattabNadia Ghannam Congresverslag 25 November 2014 Pages: 11 - 12
9. Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM - View session detail (928-P) Reinhard BretzelLouise TraylorWolfgang Landgraf Congresverslag 25 November 2014 Pages: 13 - 13
10. Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes (2425-PO) Chiara GuglielmiChiara SecchiPaolo Pozzilli Congresverslag 25 November 2014 Pages: 14 - 14
11. Antecedent recurrent hypoglycemia reduces lethal cardiac arrythmias induced by severe hypoglycemia in diabetic rats (147-OR) Bastiaan de GalanJennifer J. VanderweeleSimon J. Fisher Congresverslag 25 November 2014 Pages: 15 - 15
12. Superior glycaemic control effects with insulin degludec (IDeg) to insulin glargine (IGlar) in diabetic hemodialysis (HD) patients assessed by continuous glucose monitoring (CG M) (63-OR) Satoshi FunakoshiJyunichiro HashiguchiTakashi Harada Congresverslag 25 November 2014 Pages: 16 - 16
13. Lixisenatide as add-on treatment among patients with different beta-cell function levels as assessed by HOMA-beta index (1018-P) Riccardo C. BonadonnaLawrence BlondeMichael Horowitz Congresverslag 25 November 2014 Pages: 17 - 17
14. Glycemic control and hypoglycemia with new insulin glargine 300 U/mL in people with T1DM (EDITION 4) (80-LB (late breaking)) Philip D. HomeRichard M. BergenstalGeremia B. Bolli Congresverslag 25 November 2014 Pages: 17 - 18
15. Recombinant human hyaluronidase pretreatment of CSII cannula sites provides comparable glycemic control with reduced hypoglycemia in T1DM compared to usual CSII (85-LB) Irl B. HirschBruce W. BodeDouglas B. Muchmore Congresverslag 25 November 2014 Pages: 18 - 19
16. Implementation of New EU Driver’s License Legislation May Hamper Reporting of Severe Hypoglycemia by Patients with Type 1 Diabetes (405-P) Ulrik Pedersen-BjergaardLouise H. FærchBirger Thorsteinsson Congresverslag 25 November 2014 Pages: 19 - 19
17. Real time continuous glucose monitoring (RT-CG M) users make significant adjustments to insulin doses based on CG M rate of change arrows: comparison between users with type 1 and type 2 diabetes (836-P) Steven V. EdelmanJeremy PettusDavid A. Price Congresverslag 25 November 2014 Pages: 20 - 20
18. Acarbose Increases Gut Bacteria in Patients with Type 2 Diabetes (1040-P) Benli SuJing LiXiuxiang Meng Congresverslag 25 November 2014 Pages: 20 - 21
19. Novel Pharmacologies of Metformin in the Gut: Insights from a Washout/Redosing Paradigm in Type 2 Diabetes (1044-P) Antonella NapolitanoSam MillerDerek J. Nunez Congresverslag 25 November 2014 Pages: 21 - 21
20. Effect of Peer Leader Supported Diabetes Self-Management in Glycemic Control and Patient Centeredness (677-P) Guy RuttenLingshu XueJanice C. Zgibor Congresverslag 25 November 2014 Pages: 22 - 22
21. Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence (IDEA): A Randomized, Controlled Trial (679-P) Mark W. TrueLisa E. StricklandVictor L. Sylvia Congresverslag 25 November 2014 Pages: 25 - 25
22. Periodontal Education - A Neglected Area in The UK Diabetes Care (701-P) Kirthika JeyaramanZaineb VakilRashimi Kaushal Congresverslag 25 November 2014 Pages: 25 - 26
23. Distress and Diabetes Treatment Adherence: A Mediating Role for Perceived Control in Adults with Type 2 Diabetes (822-P) Jeffrey S. GonzalezErica ShreckSteven Safren Congresverslag 25 November 2014 Pages: 26 - 27
24. A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes (833-P) Antonio NicolucciStefania CerconeGianfranco Gensini Congresverslag 25 November 2014 Pages: 27 - 28
25. Sustained Glycemic Control with Exenatide Once Weekly (EQW) vs. Insulin Glargine (IG): Associations with Baseline Factors and Early Treatment Response (970-P) Michael TrautmannJaret MalloyJenny Han Congresverslag 25 November 2014 Pages: 28 - 28
26. Liraglutide Reverses Pronounced Insulin-Associated Weight Gain, Improves Glycemic Control, and Decreases Insulin Dose in Patients with Type 2 Diabetes (973-P) Helena de WitGerald M. VervoortCees J. Tack Congresverslag 25 November 2014 Pages: 29 - 29
27. GLP-1 RA Added to Insulin Results in Durable Weight Loss and Glycemic Control in Type 2 Diabetes Patients: 2 Years Real-Life Follow-up Data (976-P) Stefanie A. de BoerDouwe J. MulderKlaas Hoogenberg Congresverslag 25 November 2014 Pages: 29 - 30
28. Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients Using Metformin View session detail (1087-P) Huberta E. HartJoline W.J. BeulensGuy E.H.M. Rutten Congresverslag 25 November 2014 Pages: 30 - 31
29. Excessive HbA1c Testing among Patients with Controlled Non-insulin-requiring Type 2 Diabetes (1154-P) Rozalina G. MccoyHolly K. van HoutenNilay D. Shah Congresverslag 25 November 2014 Pages: 31 - 31
